IDEAS home Printed from https://ideas.repec.org/a/kap/hcarem/v16y2013i2p87-100.html
   My bibliography  Save this article

Tradeoffs in cardiovascular disease prevention, treatment, and research

Author

Listed:
  • George Miller
  • Matthew Daly
  • Charles Roehrig

Abstract

It is widely believed that the US health care system needs to transition from a culture of reactive treatment of disease to one of proactive prevention. As a tool for understanding the appropriate allocation of spending to prevention versus treatment (including research into improved prevention and treatment), a simple Markov model is used to represent the flow of individuals among states of health, where the transition rates are governed by the magnitude of appropriately-lagged expenditures in each of these categories. The model estimates the discounted cost and discounted effectiveness (measured in quality adjusted life years or QALYs) associated with a given spending mix, and it allows computing the marginal cost-effectiveness associated with additional spending in a category. We apply the model to explore interactions of alternative investments in cardiovascular disease (CVD) and to identify an optimal spending mix. Under the assumptions of our model structure, we find that the marginal cost-effectiveness of prevention of CVD varies with changes in spending on treatment (and vice versa), and that the optimal mix of CVD spending (i.e., the spending mix that maximizes the overall QALYs achieved) would, indeed, shift spending from treatment to prevention. Copyright Springer Science+Business Media New York 2013

Suggested Citation

  • George Miller & Matthew Daly & Charles Roehrig, 2013. "Tradeoffs in cardiovascular disease prevention, treatment, and research," Health Care Management Science, Springer, vol. 16(2), pages 87-100, June.
    • Handle: RePEc:kap:hcarem:v:16:y:2013:i:2:p:87-100
    DOI: 10.1007/s10729-012-9215-x
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10729-012-9215-x
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10729-012-9215-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Frank R. Lichtenberg, 2014. "Has Medical Innovation Reduced Cancer Mortality?," CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
    2. Frank R. Lichtenberg, 2006. "The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data," NBER Working Papers 12120, National Bureau of Economic Research, Inc.
    3. Tassey, Gregory, 2005. "The disaggregated technology production function: A new model of university and corporate research," Research Policy, Elsevier, vol. 34(3), pages 287-303, April.
    4. Heffley, Dennis R., 1982. "Allocating health expenditures to treatment and prevention," Journal of Health Economics, Elsevier, vol. 1(3), pages 265-290, December.
    5. Jonathan Skinner & Douglas Staiger, 2015. "Technology Diffusion and Productivity Growth in Health Care," The Review of Economics and Statistics, MIT Press, vol. 97(5), pages 951-964, December.
    6. Homer, J.B. & Hirsch, G.B., 2006. "System dynamics modeling for public health: Background and opportunities," American Journal of Public Health, American Public Health Association, vol. 96(3), pages 452-458.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gersbach, Hans & Schneider, Maik & Schneller, Olivier, 2010. "Optimal Mix of Applied and Basic Research, Distance to Frontier, and Openness," CEPR Discussion Papers 7795, C.E.P.R. Discussion Papers.
    2. Meimei Wang & Steffen Flessa, 2020. "Modelling Covid-19 under uncertainty: what can we expect?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(5), pages 665-668, July.
    3. Baltagi, Badi H. & Yen, Yin-Fang, 2014. "Hospital treatment rates and spillover effects: Does ownership matter?," Regional Science and Urban Economics, Elsevier, vol. 49(C), pages 193-202.
    4. Jeon, Sung-Hee & Pohl, R. Vincent, 2019. "Medical innovation, education, and labor market outcomes of cancer patients," Journal of Health Economics, Elsevier, vol. 68(C).
    5. Hazhir Rahmandad, 2012. "Impact of Growth Opportunities and Competition on Firm-Level Capability Development Trade-offs," Organization Science, INFORMS, vol. 23(1), pages 138-154, February.
    6. Erika Palmer, 2018. "The Heavy Cost of Care: Systemic Challenges in Norwegian Work Absenteeism," Social Sciences, MDPI, vol. 7(6), pages 1-17, June.
    7. Nicholas Bloom & Christos Genakos & Raffaella Sadun & John Van Reenen, 2011. "Management Practices Across Firms and Countries," CEP Discussion Papers dp1109, Centre for Economic Performance, LSE.
    8. Spyros Arvanitis & Euripidis N. Loukis, 2014. "Investigating the effects of ICT on innovation and performance of European hospitals," KOF Working papers 14-366, KOF Swiss Economic Institute, ETH Zurich.
    9. Elena Lucchese, 2024. "How important are delays in treatment for health outcomes? The case of ambulance response time and cardiovascular events," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 652-673, April.
    10. Simon K Chiu & Louise Freebairn & Louise A Baur & L. Kurt Kreuger & Adam Skinner & Jo‐An Occhipinti, 2023. "Modeling distribution parameters in system dynamics: an application in childhood obesity," System Dynamics Review, System Dynamics Society, vol. 39(2), pages 103-124, April.
    11. Gilleskie, Donna B. & Harrison, Amy L., 1998. "The effect of endogenous health inputs on the relationship between health and education," Economics of Education Review, Elsevier, vol. 17(3), pages 279-295, June.
    12. Johannes Schoder & Peter Zweifel, 2011. "Flat-of-the-curve medicine: a new perspective on the production of health," Health Economics Review, Springer, vol. 1(1), pages 1-10, December.
    13. French, Declan, 2014. "International mortality modelling—An economic perspective," Economics Letters, Elsevier, vol. 122(2), pages 182-186.
    14. Laurent Gobillon & Carine Milcent, 2016. "Evaluating the Effect of Ownership Status on Hospital Quality: The Key Role of Innovative Procedures," Annals of Economics and Statistics, GENES, issue 121-122, pages 161-186.
    15. Stephen Hall & P. Swamy & George Tavlas, 2012. "Generalized cointegration: a new concept with an application to health expenditure and health outcomes," Empirical Economics, Springer, vol. 42(2), pages 603-618, April.
    16. Hardcopf, Rick & Gonçalves, Paulo & Linderman, Kevin & Bendoly, Elliot, 2017. "Short-term bias and strategic misalignment in operational solutions: Perceptions, tendencies, and traps," European Journal of Operational Research, Elsevier, vol. 258(3), pages 1004-1021.
    17. Therese Riley & Liza Hopkins & Maria Gomez & Seanna Davidson & Daniel Chamberlain & Jessica Jacob & Sonia Wutzke, 2021. "A Systems Thinking Methodology for Studying Prevention Efforts in Communities," Systemic Practice and Action Research, Springer, vol. 34(5), pages 555-573, October.
    18. Raquel Fonseca & Pierre-Carl Michaud & Titus Galama & Arie Kapteyn, 2021. "Accounting for the Rise of Health Spending and Longevity," Journal of the European Economic Association, European Economic Association, vol. 19(1), pages 536-579.
    19. Zhe Zhao & Xin Xuan & Fan Zhang & Ying Cai & Xiaoyu Wang, 2022. "Scenario Analysis of Renewable Energy Development and Carbon Emission in the Beijing–Tianjin–Hebei Region," Land, MDPI, vol. 11(10), pages 1-13, September.
    20. Uchenna R. Efobi & Belmondo V. Tanankem & Simplice A. Asongu, 2018. "Female Economic Participation with Information and Communication Technology (ICT) Advancement: Evidence from Sub-Saharan Africa," Research Africa Network Working Papers 18/005, Research Africa Network (RAN).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:hcarem:v:16:y:2013:i:2:p:87-100. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.